Liver Diseases
337
40
48
159
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
33 trials with published results (10%)
Research Maturity
159 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.5%
22 terminated out of 337 trials
87.8%
+1.3% vs benchmark
8%
28 trials in Phase 3/4
21%
33 of 159 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 159 completed trials
Clinical Trials (338)
Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)
Normal Liver Stiffness by MR Elastography
Liver Micro Flow - MRI
Patients With Hepatocellular Carcinoma (HCC)
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
Primary Sclerosing Cholangitis in Children
Genetic Collection Protocol
Early Liver Disease Breath Detection
Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
A Research Study on Etavopivat in Participants With and Without Liver Disease
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)
BRIDGE Device for Post-operative Pain Control
China Metastatic Liver Cancer Clinical Registry Cohort Database
Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease